SPAC3H1.06c Antibody

What is SPAC3H1.06c antibody and what are its specifications?

SPAC3H1.06c antibody is a polyclonal antibody developed against the SPAC3H1.06c protein from Schizosaccharomyces pombe (fission yeast). This antibody serves as an important tool for detecting and studying this yeast protein in various experimental contexts .

The antibody has the following specifications:

The antibody is supplied unconjugated and has been specifically designed for research applications focusing on yeast biology .

What experimental applications is SPAC3H1.06c antibody validated for?

SPAC3H1.06c antibody has been validated for two primary applications in research settings:

• Enzyme-Linked Immunosorbent Assay (ELISA): The antibody can be used to detect and quantify SPAC3H1.06c protein in solution-based assays. This application is particularly useful for quantitative analysis of protein expression across different experimental conditions .

• Western Blotting (WB): The antibody effectively detects SPAC3H1.06c protein in denatured protein mixtures separated by gel electrophoresis. This application allows researchers to assess protein size, expression levels, and potential post-translational modifications .

While these are the validated applications, researchers may explore its utility in other immunological techniques such as immunoprecipitation or immunofluorescence microscopy, though additional validation would be required to confirm its performance in these contexts.

How should I properly validate SPAC3H1.06c antibody before use?

Proper validation of SPAC3H1.06c antibody is essential for experimental reliability and reproducibility. A comprehensive validation approach should include:

• Control testing: Utilize the provided components - 200μg antigens as positive control and 1ml pre-immune serum as negative control - to establish baseline specificity .

• Specificity assessment: Perform experiments using:

  • Wild-type yeast expressing SPAC3H1.06c

  • Knockout or knockdown strains (if available)

  • Overexpression systems

• Dilution optimization: Test a range of antibody dilutions to determine optimal concentration for your specific application. Document the optimal dilution for future reference.

• Cross-reactivity evaluation: Assess potential cross-reactivity with related proteins or in non-target species if relevant to your research questions.

• Batch validation: If using multiple antibody batches, document batch numbers and perform side-by-side comparisons to identify any batch-to-batch variations .

Understanding the immunogen used (recombinant Schizosaccharomyces pombe SPAC3H1.06c protein) provides context for interpreting results and potential cross-reactivity .

What controls should be included when working with SPAC3H1.06c antibody?

Implementing appropriate controls is fundamental for reliable antibody-based experiments. For SPAC3H1.06c antibody research, consider the following controls:

• Antigen-specific controls:

  • Positive control: Use the provided 200μg antigen preparation

  • Negative control: Use the provided 1ml pre-immune serum

  • SPAC3H1.06c knockout/knockdown samples (if available)

• Antibody controls:

  • Primary antibody omission

  • Isotype control (rabbit IgG)

  • Concentration gradient to assess signal-to-noise ratio

• Sample-specific controls:

  • Wild-type yeast samples

  • Related yeast species to assess cross-reactivity

  • Technical replicates to ensure reproducibility

• Application-specific controls:

  • For Western blotting: Loading controls (e.g., housekeeping proteins)

  • For ELISA: Standard curves using recombinant protein

The systematic implementation of these controls will help distinguish specific signals from background and validate antibody performance in your experimental system.

What are the recommended protocols for Western blotting with SPAC3H1.06c antibody?

Optimizing Western blotting with SPAC3H1.06c antibody requires attention to several key parameters:

• Sample preparation:

  • Effective yeast cell lysis (consider glass bead disruption or enzymatic methods)

  • Inclusion of protease inhibitors to prevent degradation

  • Proper protein quantification (BCA or Bradford assay)

  • Sample denaturation (typically 95°C for 5 minutes in reducing sample buffer)

• Electrophoresis conditions:

  • Choose appropriate gel percentage based on target protein size

  • Include molecular weight markers

  • Load 20-50μg total protein per lane

• Transfer parameters:

  • PVDF or nitrocellulose membrane selection

  • Transfer buffer optimization (methanol percentage, SDS inclusion)

  • Transfer time and voltage/amperage settings

• Antibody incubation:

  • Blocking: 5% non-fat dry milk or BSA in TBST (1 hour at room temperature)

  • Primary antibody: Start with 1:1000 dilution in blocking buffer (overnight at 4°C)

  • Washing: 3-5 washes with TBST (5 minutes each)

  • Secondary antibody: HRP-conjugated anti-rabbit IgG (1:5000 in blocking buffer, 1 hour at room temperature)

• Detection and analysis:

  • Enhanced chemiluminescence (ECL) detection

  • Image acquisition below saturation

  • Densitometric analysis with appropriate normalization to loading controls

Optimization table for Western blotting parameters:

How do I optimize ELISA protocols with SPAC3H1.06c antibody?

For ELISA applications with SPAC3H1.06c antibody, consider the following protocol framework:

• Plate coating:

  • For direct ELISA: Coat with sample containing SPAC3H1.06c

  • For sandwich ELISA: Coat with a capture antibody

  • Use carbonate-bicarbonate buffer (pH 9.6)

  • Incubate overnight at 4°C

• Blocking:

  • Use 1-3% BSA in PBS with 0.05% Tween-20

  • Incubate for 1-2 hours at room temperature

• Primary antibody incubation:

  • Dilute SPAC3H1.06c antibody in blocking buffer (1:1000 starting dilution)

  • Incubate for 2 hours at room temperature

• Detection system:

  • HRP-conjugated anti-rabbit secondary antibody (1:5000)

  • TMB substrate for colorimetric detection

  • Stop with 2N H₂SO₄

  • Read at 450nm

ELISA optimization considerations:

Generating a standard curve using purified recombinant SPAC3H1.06c protein is recommended for quantitative analysis.

How can I address batch-to-batch variability with SPAC3H1.06c antibody?

Batch-to-batch variability is a recognized challenge with polyclonal antibodies . For SPAC3H1.06c antibody, implement these strategies:

• Documentation and tracking:

  • Record batch numbers for each experiment

  • Maintain detailed protocols and results for each batch

  • Create a standardized validation protocol for new batches

• Comparative analysis:

  • Perform side-by-side testing when receiving a new batch

  • Generate standard curves for each batch

  • Calculate correction factors if necessary

• Inventory management:

  • Purchase sufficient quantity of a single batch for long-term projects

  • Aliquot antibodies to minimize freeze-thaw cycles

  • Store according to manufacturer recommendations (-20°C or -80°C)

• Alternative approaches:

  • If variability is problematic, consider developing monoclonal alternatives

  • Implement orthogonal detection methods to validate key findings

The specific polyclonal nature of SPAC3H1.06c antibody makes batch variation particularly relevant , and reporting batch numbers in publications enhances experimental reproducibility.

What factors might affect the specificity and sensitivity of SPAC3H1.06c antibody?

Several factors can influence the performance of SPAC3H1.06c antibody in experimental applications:

• Target protein considerations:

  • Post-translational modifications may alter epitope recognition

  • Protein conformation (native vs. denatured states)

  • Protein-protein interactions masking antibody binding sites

  • Expression level variations in different growth conditions

• Experimental parameters:

  • Sample preparation methods (lysis buffers, detergents)

  • Fixation procedures (for microscopy applications)

  • Blocking reagents and their concentration

  • Antibody concentration and incubation conditions

• Technical factors:

  • Storage conditions and freeze-thaw cycles

  • Buffer composition (pH, ionic strength)

  • Detection system sensitivity

  • Instrument calibration and settings

Methodical optimization addressing these factors will enhance both specificity and sensitivity. Cross-validation with orthogonal methods is recommended for critical findings.

How should I properly report SPAC3H1.06c antibody use in scientific publications?

Comprehensive reporting of antibody use is crucial for experimental reproducibility . For SPAC3H1.06c antibody, include:

• Antibody identification:

  • Complete name: Anti-SPAC3H1.06c Antibody

  • Type: Polyclonal

  • Host: Rabbit

  • Supplier: (e.g., Cusabio)

  • Catalog number: CSB-PA604547XA01SXV-2

  • RRID (Research Resource Identifier) if available

• Experimental parameters:

  • Application (ELISA, Western blotting)

  • Dilution or concentration used

  • Incubation conditions

  • Batch number (especially if variation was observed)

• Validation information:

  • Controls employed

  • Validation experiments performed

  • Known limitations

• Antigen details:

  • Immunogen: Recombinant Schizosaccharomyces pombe SPAC3H1.06c protein

  • Epitope information (if known)

As emphasized in the literature, closely linking antibody information with application details in methods sections improves clarity and reproducibility .

How do I quantitatively analyze Western blot data using SPAC3H1.06c antibody?

Quantitative analysis of Western blot data requires systematic approaches to ensure accuracy and reproducibility:

• Image acquisition:

  • Capture images within the linear dynamic range of detection

  • Avoid pixel saturation

  • Include molecular weight markers

  • Use consistent exposure settings across comparative samples

• Densitometric analysis:

  • Use specialized software (ImageJ, ImageLab, etc.)

  • Define regions of interest consistently

  • Subtract background signal

  • Normalize to appropriate loading controls

• Normalization strategies:

  • Housekeeping proteins (with caution regarding experimental conditions)

  • Total protein staining (Ponceau S, SYPRO Ruby)

  • Relative quantification to control samples

• Statistical analysis:

  • Perform replicate experiments (minimum n=3)

  • Apply appropriate statistical tests

  • Report variability (standard deviation, standard error)

  • Consider the biological significance of quantitative differences

A standardized quantification workflow enhances reproducibility across experiments and facilitates meaningful comparisons between experimental conditions.

How can I integrate SPAC3H1.06c antibody data with other experimental approaches?

Combining antibody-based detection with complementary techniques provides more comprehensive insights:

• Multi-technique integration:

  • Compare protein levels (antibody detection) with mRNA expression (RT-qPCR, RNA-seq)

  • Correlate protein detection with functional assays

  • Link localization data from fractionation with immunodetection

  • Integrate with proteomics data for pathway analysis

• Genetic approaches:

  • Validate antibody specificity with knockout/knockdown models

  • Complement with overexpression systems

  • Use tagged constructs for orthogonal detection

• Functional correlation:

  • Associate protein levels with phenotypic outcomes

  • Link protein expression to metabolic pathways

  • Correlate post-translational modifications with functional states

• Data integration methods:

  • Correlation analysis between different data types

  • Network analysis to identify functional relationships

  • Temporal studies to establish causality

Example integration workflow:

This multi-faceted approach enhances confidence in results and provides deeper biological insights.

How can I use SPAC3H1.06c antibody to study protein-protein interactions?

SPAC3H1.06c antibody can be adapted for studying protein-protein interactions through several methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Use SPAC3H1.06c antibody to pull down the target protein

  • Analyze co-precipitated proteins by Western blotting or mass spectrometry

  • Include appropriate controls (IgG control, knockout samples)

  • Consider native vs. crosslinked conditions

• Proximity ligation assay (PLA):

  • Combine SPAC3H1.06c antibody with antibodies against potential interacting partners

  • Visualize protein proximity through fluorescent signal amplification

  • Quantify interaction signals in different cellular compartments

• Far-Western analysis:

  • Use purified protein probes on membranes

  • Detect interactions with SPAC3H1.06c antibody

  • Compare interaction profiles under different conditions

• Immunofluorescence co-localization:

  • Perform dual labeling with SPAC3H1.06c antibody and antibodies against candidate interactors

  • Analyze co-localization using confocal microscopy

  • Quantify spatial correlation using appropriate metrics

Each method offers distinct advantages and limitations, and combining multiple approaches provides stronger evidence for biologically relevant interactions.

What strategies can I use to study post-translational modifications of SPAC3H1.06c?

Investigating post-translational modifications (PTMs) of SPAC3H1.06c requires specialized approaches:

• PTM-specific detection:

  • Use phospho-specific antibodies if phosphorylation sites are known

  • Combine with general SPAC3H1.06c antibody to determine modification stoichiometry

  • Employ dephosphorylation treatments as controls

• Gel mobility analysis:

  • Compare migration patterns under different conditions

  • Use Phos-tag gels for phosphorylation analysis

  • Perform two-dimensional gel electrophoresis to separate modified forms

• Mass spectrometry integration:

  • Immunoprecipitate SPAC3H1.06c using the antibody

  • Analyze by mass spectrometry for PTM identification

  • Quantify modification levels across conditions

• Functional correlation:

  • Compare PTM status with functional outcomes

  • Study dynamics of modifications under different stimuli

  • Investigate enzymes responsible for adding/removing modifications

Example workflow for phosphorylation analysis:

• Immunoprecipitate SPAC3H1.06c from yeast lysates

• Split sample and treat half with phosphatase

• Perform Western blotting to detect mobility shifts

• Submit samples for mass spectrometry analysis

• Correlate phosphorylation with cellular conditions or stresses

What are the current limitations of SPAC3H1.06c antibody research and future directions?

Current limitations in SPAC3H1.06c antibody research include:

• Technical challenges:

  • Potential batch-to-batch variability inherent to polyclonal antibodies

  • Limited validated applications (currently ELISA and Western blotting)

  • Potential cross-reactivity with homologous proteins

• Knowledge gaps:

  • Incomplete understanding of epitope specificity

  • Limited published validation across diverse experimental conditions

  • Undetermined performance in advanced applications (ChIP, IF, IHC)

Future research directions to advance SPAC3H1.06c antibody applications:

• Methodological improvements:

  • Development of monoclonal alternatives to reduce variability

  • Expansion of validated applications

  • Creation of modification-specific antibodies

• Technological integration:

  • Combination with CRISPR-based approaches for validation

  • Integration with advanced imaging techniques

  • Development of multiplexed detection systems

• Standardization efforts:

  • Establishment of reference standards for quantification

  • Development of shared validation protocols

  • Creation of community resources for antibody performance data